Dna Script SAS
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Method for preparing 3′-o-amino-2′-deoxyribonucleoside-5′-triphosphates (US 11,661,436) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for Terminal deoxynucleotidyl transferase variants and uses thereof (US 11,859,217) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 20, 2027The maintenance fee for Efficient Product Cleavage in Template-Free Enzymatic Synthesis of Polynucleotides (US 11,905,541) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,913,964 | Method for synthesizing nucleic acids, in particular long nucleic acids, use of said method and kit for implementing said method In force · From the USPTO record | In force | From the USPTO record | |
| US 12,071,638 | Variants of Terminal Deoxynucleotidyl Transferase and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 12,371,680 | Terminal deoxynucleotidyl transferase variants and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,268,091 | Direct oligonucleotide synthesis on cells and biomolecules In force · From the USPTO record | In force | From the USPTO record | |
| US 11,859,217 | Terminal deoxynucleotidyl transferase variants and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,359,221 | Efficient Product Cleavage in Template-Free Enzymatic Synthesis of Polynucleotides In force · High confidence | In force | High confidence | |
| US 11,905,541 | Efficient Product Cleavage in Template-Free Enzymatic Synthesis of Polynucleotides In force · High confidence | In force | High confidence | |
| US 12,674,186 | Efficient Product Cleavage in Template-Free Enzymatic Synthesis of Polynucleotides In force · Medium confidence | In force | Medium confidence | |
| US 11,312,742 | Process for preparing 3'-O-amino-ribonucleotide In force · From the USPTO record | In force | From the USPTO record | |
| US 11,993,773 | Methods for extending polynucleotides In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 11: 4 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 no status recorded